Aligning Science Across Parkinson's (ASAP)
Overview
Aligning Science Across Parkinson's (ASAP) is a coordinated research initiative to accelerate discoveries for Parkinson's disease. ASAP fosters collaboration and resources to better understand the underlying causes of Parkinson's disease. With scale, transparency, and open access data sharing, ASAP aims to accelerate the pace of discovery and inform the path to a cure.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Acurex Biosciences | May 2026 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Aligning Science Across Parkinson's (ASAP) based?
Aligning Science Across Parkinson's (ASAP) is headquartered in Chevy Chase, Maryland, United States.
When was Aligning Science Across Parkinson's (ASAP) founded?
Aligning Science Across Parkinson's (ASAP) was founded in 2019.
How many portfolio companies does Aligning Science Across Parkinson's (ASAP) have?
Aligning Science Across Parkinson's (ASAP) has 1 portfolio company in Caplight's dataset.
What are some companies in Aligning Science Across Parkinson's (ASAP)'s portfolio?
Portfolio companies visible on Caplight include Acurex Biosciences.
What was Aligning Science Across Parkinson's (ASAP)'s most recent investment shown here?
Aligning Science Across Parkinson's (ASAP)'s most recent investment in this portfolio sample was in Acurex Biosciences in 2026.
What sectors does Aligning Science Across Parkinson's (ASAP) focus on?
Aligning Science Across Parkinson's (ASAP) focuses on Healthcare & Life Sciences.
What company stages does Aligning Science Across Parkinson's (ASAP) focus on?
Stage focus information for Aligning Science Across Parkinson's (ASAP) is not publicly available.
What is Aligning Science Across Parkinson's (ASAP)'s AUM?
Aligning Science Across Parkinson's (ASAP)'s assets under management are estimated between $250.0M and $500.0M.